Sonoma Pharmaceuticals (SNOA) Finished Goods (2012 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Finished Goods of $2.0 million for Q4 2025, down 2.74% year-over-year from $2.0 million in Q4 2024, and down 0.71% quarter-over-quarter from $2.0 million in Q3 2025.
Sonoma Pharmaceuticals (SNOA) Finished Goods (2012 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Finished Goods history runs 13 years deep, the most recent figure standing at $2.0 million for Q4 2025.
- In Q4 2025, Finished Goods fell 2.74% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 2.74% YoY), while the FY2025 annual figure was $1.8 million, up 49.88% from the prior year.
- Finished Goods for Q4 2025 stood at $2.0 million, down from $2.0 million in the prior quarter.
- The five-year high for Finished Goods was $2.4 million in Q2 2025, with the low at $773000.0 in Q3 2021.
- The 5-year median for Finished Goods is $1.2 million (2021), against an average of $1.4 million.
- The sharpest annual moves came in 2021 and 2025: Finished Goods plunged 51.87% in 2021, then jumped 91.92% in 2025.
- Sonoma Pharmaceuticals' Finished Goods stood at $1.3 million in 2021, then declined by 1.12% to $1.2 million in 2022, then advanced by 16.96% to $1.4 million in 2023, then soared by 38.54% to $2.0 million in 2024, then slipped by 2.74% to $2.0 million in 2025.
- Business Quant data shows SNOA's Finished Goods at $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $2.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 773,000.00 |